781125008: Fremanezumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance)\Fremanezumab (substance)

\Drug or medicament (substance)\Monoclonal antibody\Fremanezumab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Fremanezumab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Fremanezumab (substance)

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Fremanezumab (substance)
\Biological substance\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Fremanezumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3744983010 Fremanezumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3744984016 Fremanezumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1137981000172118 fremanezumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

1128181000172118 fremanezumab nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Fremanezumab (substance)	Has disposition (attribute)	Calcitonin gene-related peptide receptor antagonist (disposition)	true	Inferred relationship	Some
Fremanezumab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Fremanezumab (substance)	Is a	Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fremanezumab-containing product	Has active ingredient	True	Fremanezumab (substance)	Inferred relationship	Some	1
Fremanezumab only product	Has active ingredient	True	Fremanezumab (substance)	Inferred relationship	Some	1
Product containing only fremanezumab in parenteral dose form (medicinal product form)	Has active ingredient	True	Fremanezumab (substance)	Inferred relationship	Some	1
Fremanezumab-containing product in parenteral dose form	Has active ingredient	True	Fremanezumab (substance)	Inferred relationship	Some	1
Product containing precisely fremanezumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Fremanezumab (substance)	Inferred relationship	Some	1
Product containing precisely fremanezumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Fremanezumab (substance)	Inferred relationship	Some	1

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug